Fosaprepitant Intravenous and Omalizumab Subcutaneous
Determining the interaction of Fosaprepitant Intravenous and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Ombitasvir, Paritaprevir, and Ritonavir
- Fosaprepitant Intravenous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Fosaprepitant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Fosaprepitant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Fosaprepitant Intravenous-Omeclamox-Pak
- Fosaprepitant Intravenous-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Foscarnet
- Omalizumab Subcutaneous-Foscarnet Intravenous
- Omalizumab Subcutaneous-Foscarnet Sodium
- Omalizumab Subcutaneous-Foscavir
- Omalizumab Subcutaneous-Fosfomycin
- Omalizumab Subcutaneous-Fosfomycin Tromethamine